Arkolith/Insider Trading/CMMB/Form 4

Cohen Neil Harris

DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 15, 2022
Net Buying
Open-Market Buys
$26K
Open-Market Sells
$0
Net Open-Market Flow
$26K
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2022Buy(P)2K$4.56$9K10K
Mar 14, 2022Buy(P)2K$4.30$9K8K
Mar 14, 2022Buy(P)2K$4.20$8K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2022Grant(A)7K—$07K
Apr 19, 2021Grant(A)12K—$012K
Mar 16, 2021Grant(A)688—$0688

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-001117) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML